TRPA1 activation is associated with a non-canonical oxidative-stress defense, as well as a canonical ROS-neutralizing mechanism, thus upregulating anti-apoptotic pathways that favor cancer progression [36]. The gene discussed is TRPA1; the disease is cancer.